Correction to: Long-term oral anticoagulation reduces bone mass in patients with previous hemispheric infarction and nonrheumatic atrial fibrillation (Stroke (1997) 28 (2390-2394) DOI: 10.1161/01.STR.28.12.2390);Long-term oral anticoagulation reduces bone mass in patients with previous hemispheric infarction and nonrheumatic atrial fibrillation

Stroke

Volumn 28, Issue 12, 1997, Pages 2390-2394

  Sato, Yoshihiro ^a,c   Honda, Yoshiaki ^a   Kunoh, Haruko ^a   Oizumi, Kotaro ^b  

^a Futase Social Insurance Hospital   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KURUME UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Atrial fibrillation; Bone; Osteoporosis; Vitamin K; Warfarin

Indexed keywords

VITAMIN K GROUP;

ADULT; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; BONE MASS; BONE MATRIX; BONE METABOLISM; BONE MINERAL; BRAIN INFARCTION; CARBOXYLATION; FEMALE; HEART ATRIUM FIBRILLATION; HEMIPLEGIA; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION;

EID: 0031456520     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STR.0000000000000199     Document Type: Erratum

References (47)

1. Vermeer C, Jie KSG, Knapen MHJ. Role of vitamin K in bone metabolism. Annu Rev Nutr. 1995;15:1-22.
2. Shearer MJ. Vitamin K. Lancet. 1995;345:229-234.
3. Szulc P, Arlot M, Chapuy MC, Meunier PJ, Delmas PD. Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res. 1994;9:1591-1595.
4. Szulc P, Chapuy MC, Meunier PJ, Delmas PD. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest. 1993;91:1769-1774.
5. Hart JP, Shearer MJ, Klenerman L, Catterall A, Reeve J, Sambrook PN, Dodds RA, Bitensky L, Chayen J. Electrochemical detection of depressed circulating levels of vitamin K1 in osteoporosis. J Clin Endocrinol Metab. 1985;60:1268-1269.
6. Bitensky L, Hart JP, Catterrall A, Hodges SJ, Pilkington MJ, Chayen J. Circulating vitamin K levels in patients with fractures. J Bone Joint Surg Br. 1988;70:663-662.
7. Hodges SJ, Pilkington MJ, Stamp TCB, Catterall A, Shearer MJ, Bitensky L, Chayen J. Depressed levels of circulation menaquinones in patients with osteoporotic fractures of the spine and femoral neck. Bone. 1991;12:387-389.
8. 2 decreased in elderly women with hip fractures. J Bone Miner Res. 1993;8:1241-1245.
9. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med. 1990;323:1505-1511.
10. Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol. 1991;18:349-355.
11. Ezekowittz MD, Bridgers SL, James KE, Carliner NH, Colling CL, Gornick CC, Krause-Steinrauf H, Kurtzke JF, Nazarian SM, Radford MJ, Rickles FR, Shabetai R, Deykin D. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med. 1993;328:1406-1412.
12. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study. Lancet. 1989;1:175-179.
13. Stroke Prevention in Atrial Fibrillation Investigators. Preliminary report of the Stroke Prevention in Atrial Fibrillation Study. N Engl J Med 1990;322:863-868.
14. Idem. Stroke Prevention in Atrial Fibrillation Study: final results. Circulation. 1991;84:527-539.
15. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet. 1993;342:1255-1262.
16. The European Atrial Fibrillation Trial Study Group. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med. 1995;333:5-10.
17. Price PA, Williamson MK. Effects of warfarin on bone. J Biol Chem. 1981;256:12754-12759.
18. Fiore CE, Tamburino C, Foti R, Grimaldi D. Reduced axial bone mineral content in patients with taking an oral anticoagulant. South Med J. 1990;83:538-542.
19. Philip WJU, Martin JC, Richardson JM, Reid DM, Webster J, Douglas AS. Decreased axial and peripheral bone density in patients with taking long-term warfarin. Q J Med. 1995;88:635-640.
20. Sato Y, Maruoka H, Honda Y, Asoh T, Fujimatsu Y, Oizumi K. Development osteopenia in the hemiplegic finger in patients with stroke. Eur Neurol. 1996;36:278-283.
21. Sato Y, Maruoka H, Oizumi K, Kikuyama M. Vitamin D deficiency and osteopenia in the hemiplegic limbs of stroke patients. Stroke. 1996;27:2183-2187.
22. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md Med J. 1965;14:61-65.
23. Brunstrom S: Motor testing procedures in hemiplegia: based on sequential recovery stages. Am J Phys Ther. 1966;46:357-375.
24. Inoue T, Orimo H, Koshikawa S, Ross PD, Gallagher JC, Kanis JA. Acronym of improved microdensitometry (computed x-ray densitometry). J Bone Miner Met. 1994;12:145. Letter.
25. Mastumoto C, Kushida K, Yamazaki K, Imose K, Inoue T. Metacarpal bone mass in normal and osteoporotic Japanese women using computed X-ray densitometry. Calcif Tissue Int. 1994;55: 324-329.
26. Langenberg JP, Tjaden UR. Improved method for the determination of vitamin K1 epoxide in human plasma with electrofluorimetric reaction detection. J Chromatogr. 1984;289:377-385.
27. Kanai T, Takagi T, Masuhiro K, Nakamura M, Iwata M, Saji F. Serum vitamin K level and hone mineral density in post-menopausal women. Int J Gynaecol Obstet. 1997;56:25-30.
28. Jie KSG, Bots ML, Vermeer C, Witteman JCM, Grobbee DE. Vitamin K status and bone mass in women with or without aortic atherosclerosis: a population-based study. Calcif Tissue Int. 1996; 59:352-356.
29. Pastoureau P, Vergnaud P, Meunier PJ, Delmas PD. Osteopenia and bone-remodeling abnormalities in warfarin-treated lambs. J Bone Miner Res. 1993;8:1417-1426.
30. Vermeer C, Gijsbers BLMG, Crāckin AM, Groenen-Van Dooren MMCL, Knapen MHJ. Effects of vitamin K on bone mass and bone metabolism. J Nutr 1996;126:1187S-1191S.
31. Orimo H, Fujita T, Onomura T, Inoue T, Kushida K, Shiraki M. Clinical effects of menantetrenone to osteoporosis [in Japanese]. Shinyaku To Rinshyo. 1992;41:1249-1279.
32. Hara K, Akiyama Y, Ohkawa I, Tajima T. Effects of menantetrenone on prednisolone-induced bone loss in rats. Bone. 1993;14: 813-818.
33. Hara K, Akiyama Y, Tajima T, Shiraki M. Menantetrenone inhibits bone resorption partly through inhibition of PGE2 synthesis in vitro. J Bone Miner Res. 1993;8:535-542.
34. Akiyama Y, Hara K, Ohkawa I, Tajima T. Effects of menantetrenone on bone loss induced by ovariectomy in rats. Jpn J Pharmacol. 1993;62:145-153.
35. Matsumoto C, Kushida K, Orimo H, Koshikawa S, Shiraki M, Akimoto T, Inoue T, Tagawa H. A new computed x-ray densitometer and its performance [in Japanese with English abstract]. J Clin Exp Med. 1991;156:741-742.
36. Min Lai S, Alter M, Friday G, Sobel E. A multifactorial analysis of risk factors for recurrence of ischemic stroke. Stroke. 1994;25: 958-962.
37. Van Latum JC, Koudstaal PJ, Venables GS, Van Ginn J, Kappelle LJ, Algra A, for the European Atrial Fibrillation Trial (EAFT) Study Group. Predictors of major vascular event in patients with a transient ischemic attack or minor ischemic stroke and with non-rheumatic atrial fibrillation. Stroke. 1995;26:801-806.
38. Peszczynski M. The fractured hip in hemiplegic patients. Geriatrics. 1957;12:687-690.
39. Mulley G, Espley AJ. Hip fracture after hemiplegia. Postgrad Med J. 1979;55:264-265.
40. Poplingher AR, Pillar T. Hip fracture in stroke patients. Acta Orthop Scand. 1985;56:226-227.
41. Hooper G. Internal fixation of fractures of the neck of the femur in hemiplegic patients. Injury. 1979;10:281-284.
42. Chiu KY, Pun WK, Luk KDK, Chow SP. A prospective study on hip fractures in patients with previous cerebrovascular accidents. Injury. 1992;23:297-299.
43. Grisso JA, Kelsey JL, Strom BL, Chiu GY, Maislin G, O'Brien LA, Hoffman S, Kaplan F. Risk factors for falls as a cause of hip fracture in women. N Engl J Med. 1991;324:1326-1331.
44. Sato Y, Maruoka H, Oizumi K. Amelioration of hemiplegia-associated osteopenia over 4 years following stroke by 1 a-hydroxyvitamin D3 and calcium supplementation. Stroke. 1997; 28:736-739.
45. Sato Y, Fujimatsu Y, Honda Y, Kuno H, Kikuyama M, Oizumi. Accelerated bone remodeling in the patients with poststroke hemiplegia. J Stroke Cerebrovasc Dis. In press.
46. Carano A, Teitelbaum SL, Konsek JD, Schlessinger PH, Blair HC. Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro. J Clin Invest. 1990;85:456-461.
47. Strom T, Steiniche T. Thamsborg G, Melsen F. Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis. J Bone Miner Res. 1993;8:199-208.